Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c05926 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Zhuang Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan …. Hauptthemen laut MEDLINE: Nanoparticles, Colorectal Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, Wuhan 430071, China.
ORCID-Profile: Zhuang Hu, Zilin Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, Z., Li, R., Cui, X., & Chen, Z. (2023). Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c05926
Vancouver
Hu Z, Li R, Cui X, Chen Z. Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c05926
BibTeX
@article{Hu2023,
author = {Hu, Zhuang and Li, Ruihan and Cui, Xinyue and Chen, Zilin},
title = {Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c05926}
}
EUVIMED